Prognostic factors in elderly patients with supratentorial malignant gliomas

Neurologia Medico-Chirurgica

Volumn 47, Issue 12, 2007, Pages 543-549

  Kurimoto, Masanori ^a   Nagai, Shoichi ^a   Kamiyama, Hironaga ^a   Tsuboi, Yoshifumi ^a   Kurosaki, Kunikazu ^a   Hayashi, Nakamasa ^a   Origasa, Hideki ^a   Endo, Shunro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Elderly patient; Malignant astrocytoma; Performance status; Radiation therapy; Survival time

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ELDERLY CARE; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURVIVAL TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 37749028774     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.47.543     Document Type: Article

References (45)

1. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG: A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29: 835-839, 1994
2. Baumert BG, Lutterbach J, Bernays R, Davis JB, Heppner FL: Fractionated stereotactic radiotherapy boost after post-operative radiotherapy in patients with high-grade gliomas. Radiother Oncol 67: 183-190, 2003
3. Brada M, Stenning SP: Radiotherapy for malignant gliomas in the elderly. Semin Oncol 30 (6 Suppl 19): 63-67, 2003
4. Brandes AA, Compostella A, Blatt V, Tosoni A: Glioblastoma in the elderly: current and future trends. Crit Rev Oncol Hematol 60: 256-266, 2006
5. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M: A prospective study on glioblastoma in the elderly. Cancer 97: 657-662, 2003
6. Brell M, Ibanez J, Caral L, Ferrer E: Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 142: 739-750, 2000
7. Cabantog AM, Bernstein M: Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci 21: 213-218, 1994
8. Chinot OL, Barrie M, Frauger E, Dufour H, Figarella-Branger D, Palmari J, Braguer D, Hoang-Xuan K, Moktari K, Peragut JC, Martin PM, Grisoli F: Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100: 2208-2214, 2004
9. Committee of Brain Tumor Registry of Japan: Report of Brain Tumor Registry of Japan (1969-1996). Neurol Med Chir (Tokyo) 43 Suppl: 1-111, 2003
10. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710, 1993
11. Davis DL, Hoel D, Fox J, Lopez A: International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 336: 474-481, 1990
12. Deorah S, Lynch CF, Sibenaller ZA, Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20(4): E1, 2006
13. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms: A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78: 767-775, 1993
14. Fleury A, Menegoz F, Grosclaude P, Daures JP, Henry-Amar M, Raverdy N, Schaffer P, Poisson M, Delattre JY: Descriptive epidemiology of cerebral gliomas in France. Cancer 79: 1195-1202, 1997
15. Fujimura M, Kumabe T, Tominaga T, Jokura H, Shirane R, Yoshimoto T: Routine clinical adoption of magnetic resonance imaging was associated with better outcome after surgery in elderly patients with a malignant astrocytic tumour: a retrospective review. Acta Neurochir (Wien) 146: 251-255, 2004
16. Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD: Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer 97: 2262-2266, 2003
17. Grau JJ, Verger E, Brandes AA, Rigon A, Monfardini S, DeAngelis LM: Radiotherapy of the brain in elderly patients. Eur J Cancer 36: 443-452, 2000
18. Greig NH, Ries LG, Yancik R, Rapoport SI: Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 82: 1621-1624, 1990
19. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, Marymont MH, Cozzens JW, Levy RM, Salehi S: Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 57: 684-692, 2005
20. Keles GE, Anderson B, Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52: 371-379, 1999
21. Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34: 62-67, 1994
22. Kowalczuk A, Macdonald RL, Amidei C, Dohrmann G 3rd, Erickson RK, Hekmatpanah J, Krauss S, Krishnasamy S, Masters G, Mullan SF, Mundt AJ, Sweeney P, Vokes EE, Weir BK, Wollman RL: Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery 41: 1028-1038, 1997
23. Kreth FW, Berlis A, Spiropoulou V, Faist M, Scheremet R, Rossner R, Volk B, Ostertag CB: The role of tumor resection in the treatment of glioblastoma multiforme in adults. Cancer 86: 2117-2123, 1999
24. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R: A multivariate analysis of 416 patients with glioblastoma multiforme: Prognosis, extent of resection, and survival. J Neurosurg 95: 190-198, 2001
25. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S; Glioma Outcomes Investigators: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99: 467-473, 2003
26. Lowry JK, Snyder JJ, Lowry PW: Brain tumors in the elderly: recent trends in a Minnesota cohort study. Arch Neurol 55: 922-928, 1998
27. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, Anile C: Glioblastoma multiforme in the elderly: A therapeutic challenge. J Neurooncol 76: 159-163, 2006
28. Marijnen CA, van den Berg SM, van Duinen SG, Voormolen JH, Noordijk EM: Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 75: 210-216, 2005
29. Meckling S, Dold O, Forsyth PA, Brasher P, Hagen NA: Malignant supratentorial glioma in the elderly: is radiotherapy useful? Neurology 47: 901-905, 1996
30. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH: Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42: 981-987, 1998
31. Muacevic A, Kreth FW: Quality-adjusted survival after tumor resection and/or radiation therapy for elderly patients with glioblastoma multiforme. J Neurol 250: 561-568, 2003
32. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73: 331-344, 1990
33. Patwardhan RV, Shorter C, Willis BK, Reddy P, Smith D, Caldito GC, Nanda A: Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy. Surg Neurol 62: 207-215, 2004
34. Pierga JY, Hoang-Xuan K, Feuvret L, Simon JM, Cornu P, Baillet F, Mazeron JJ, Delattre JY: Treatment of malignant gliomas in the elderly. J Neurooncol 43: 187-193, 1999
35. Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29: 385-389, 1991
36. Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, Kurland LT: The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol 37: 67-73, 1995
37. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P: Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22: 1583-1588, 2004
38. Salminen E, Nuutinen JM, Huhtala S: Multivariate analysis of prognostic factors in 106 patients with malignant glioma. Eur J Cancer 32A: 1918-1923, 1996
39. Stark AM, Hedderich J, Held-Feindt J, Mehdorn HM: Glioblastoma - the consequences of advanced patient age on treatment and survival. Neurosurg Rev 30: 56-62, 2007
40. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005
41. Tomita T, Raimondi AJ: Brain tumors in the elderly. JAMA 246: 53-55, 1981
42. Villa S, Vinolas N, Verger E, Yaya R, Martinez A, Gil M, Moreno V, Caral L, Graus F: Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42: 977-980, 1998
43. Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen J: Debulking or biopsy of malignant glioma in elderly people: A randomised study. Acta Neurochir (Wien) 145: 5-10, 2003
44. Werner MH, Phuphanich S, Lyman GH: The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly. Cancer 76: 1634-1642, 1995
45. Whittle IR, Basu N, Grant R, Walker M, Gregor A: Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome. Br J Neurosurg 16: 343-347, 2002